169331 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#3002BIOMARKERS TO IMPROVE PREDICTION OF HEART FAILURE RISK
#3003BIOMARKERS FOR THE DIAGNOSIS OF INTERSTITIAL CYSTITIS
#3004Multiplex MRM assay for evaluation of cancer
#3005Tau imaging probe
#3006Modulators of ATP-binding cassette transporters
#3007Salivary biomarkers for monitoring of type 2 diabetes treatment
#3008Method for diagnosing inflammatory bowel disease
#3009Relevance of achieved levels of markers of systemic inflammation following treatment
#3010Brucellosis, Q-fever, and lyme disease biomarkers and uses thereof
#3011Anti-alphavbeta1 integrin inhibitors and methods of use
#3012METHODS FOR TREATING LUNG DISEASE
#3013Compositions and Methods for Diagnosing and Treating Diseases and Disorders Associated With D-DT
#3014Phenyl glyoxal probes
#3015Diagnostic method for urinary tract infection
#3016Assessing renal structural alterations and outcomes
#3017Assays for determining plasma kallikrein system biomarkers
#3018A METHOD FOR PREDICTING THE RISK OF GETTING A MAJOR ADVERSE CARDIAC EVENT
#3019Mycobacterial antigen composition
#3020Anti-LPS enriched immunoglobulin for use in treatment and/or prophylaxis of fibrosis
#3021Galectin-3 as immunological target
#3022L-FABP BASED DIAGNOSIS OF KIDNEY INJURY AFTER AN ACUTE EVENT OR AFTER A SURGICAL INTERVENTION
#3023LTBP2 AS A BIOMARKER FOR RENAL DYSFUNCTION
#3024Biomarkers for Cell Therapy
#3025Methods and compositions for diagnosis and prognosis of appendicitis and differentiation of causes of abdominal pain
#3026Methods, Systems and Kits of Fecal NGal Rapid Immunochromatographic Test
#3027Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
#3028URINARY NEUROPILIN-1 (NRP-1) AS A PROGNOSTIC MARKER FOR NEPHRITIS AND LUPUS NEPHRITIS
#3029Methods for predicting the progression and treating a chronic kidney disease in a patient
#3030Compositions and methods for treating cancer with JAK2 activity
#3031Methods of diagnosing and treating neonatal reversion to fetal consciousness
#3032Diagnostic reagents and methods specific to inner ear disorders
#3033METHOD FOR DIAGNOSING AN INFLAMMATORY CONDITION IN THE FEMALE GENITAL TRACT
#3034Biomarkers for diagnosis of transient ischemic attacks
#3035Methods and assays relating to the treatment of infection
#3036Ultra-small apoB-containing particles and methods of use thereof
#3037Compositions and Methods for Evaluating Metabolic Syndrome and Related Diseases
#3038Biomarkers for Tuberculosis
#3039Methods and Devices for Detecting Kidney Damage
#3040Methods and kits for determining von Willebrand factor activity in the absence of ristocetin
#3041Device and methods of using device for detection of hyperammonemia
#3042Methods and kits for determining predisposition to develop kidney diseases
#3043METHODS OF PROGNOSING, DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSIS
#3044TM4SF1 binding proteins and methods of using same
#3045Method of treating or improving neurological function in a human subject
#3046Therapy for subarachnoid hemorrhage and ischemia
#3047METHODS AND KITS FOR DIAGNOSING AND/OR PROGNOSING OSTEOARTHRITIS
#3048NOVEL NON-INVASIVE METHODS OF MONITORING HIV VIRAL LOADS
#3049Combined biomarker measurement of fibrosis
#3050METHOD OF TREATING AND PROGNOSING SCOLIOTIC PATIENT SUBGROUPS
#3051Improved Lateral Flow Assays
#3052Method for pathogen isolation
#3053Prevention of tissue ischemia and related methods
#3054Compositions and methods for treatment of diabetic retinopathy
#3055Kidney disease biomarker
#3056Kits for classifying a subject having or at risk for developing idiopathic scoliosis
#3057Miox antibody and assay
#3058Blood biomarkers for suicidality
#3059FasR antibodies and methods of use
#3060Heterocyclic molecules for biomedical imaging and therapeutic applications
#3061Treatment of chronic obstructive pulmonary disease (COPD)
#3062BIOMARKERS FOR LOWER URINARY TRACT SYMPTOMS (LUTS)
#3063USE OF BIOMARKERS FOR ASSESSING TREATMENT OF GASTROINTESTINAL INFLAMMATORY DISORDERS WITH BETA7 INTEGRIN ANTAGONISTS
#3064Methods of diagnosing, classifying and treating endometrial cancer and precancer
#3065Detection and removal of misfolded proteins/peptides
#3066Human monoclonal antibodies specific for glypican-3 and use thereof
#3067Methods and compositions for the treatment of symptoms of Williams Syndrome
#3068CLINICAL DIAGNOSIS OF HEPATIC FIBROSIS USING A NOVEL PANEL OF LOW ABUNDANT HUMAN PLASMA PROTEIN BIOMARKERS
#3069BIOMARKERS ASSOCIATED WITH DIABETES AND FIBROSIS
#3070WELLNESS PANEL FOR COMPANION ANIMALS
#3071TEST PAPER FOR DETECTION OF DIABETIC NEPHROPATHY
#3072Highly sensitive system and method for analysis of troponin
#3073Aptamers screening method based on graphene without target immobilization and the aptamers obtained from the method
#3074Blood based biomarkers for diagnosing atherosclerotic coronary artery disease
#3075Diagnosis and treatment of incipient diabetes
#3076Cytotoxic T cell response modifiers
#3077Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
#3078Carbazole-containing sulfonamides as cryptochrome modulators
#3079Non-invasive system for calculating a human or animal, reliable, standardized and complete score
#3080Factors
#3081Type 1 Diabetes Biomarkers
#3082Assay for nitrated and total hemopexin in fluid samples
#3083METHOD OF DIAGNOSING SEPSIS OR SEPSIS RISK
#3084Method for evaluating the risk of mortality in patients who exhibit a systemic inflammatory response syndrome (SIRS) or sepsis
#3085Methods of treatment of HSCT-associated thrombotic microangiopathy with eculizumab
#3086COMPOSITIONS AND METHODS FOR THE REMOVAL OF BIOFILMS
#3087TREATMENT OF PERITONEAL INJURY USING JAK INHIBITORS
#3088Detection and treatment of LRP4-associated neurotransmission disorders
#3089Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer
#3090METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF DISEASES CHARACTERIZED BY VASCULAR LEAK, HYPOTENSION, OR A PROCOAGULANT STATE
#3091METHODS FOR DETECTING AMYLOID BETA AMYLOIDOSIS
#3092METHODS FOR DIAGNOSING AND TREATING INFLAMMATORY BOWEL DISEASE
#3093Multi-protein biomarker assay for brain injury detection and outcome
#3094BIOMARKERS FOR COGNITIVE DYSFUNCTION DISEASES AND METHOD FOR DETECTING COGNITIVE DYSFUNCTION DISEASE USING BIOMARKERS
#3095BIOMARKERS ASSOCIATED WITH AGE-RELATED MACULAR DEGENERATION
#3096Use of markers in the diagnosis and treatment of prostate cancer
#3097Biomarkers for cardiovascular diseases and methods using the same
#3098Method of modulating the activity of adrenomedullin in a subject in need of therapeutic intervention for organ dysfunction or organ failure associated with adranomedullin (ADM) activity by administering an anti-adrenomedullin (ADM) antibody or an anti-ADM antibody fragment to the subject
#3099NOVEL ALTERNATIVE SPLICE TRANSCRIPTS FOR MHC CLASS I RELATED CHAIN ALPHA (MICA) AND USES THEREOF
#3100Methods of treating pre-eclampsia or eclampsia
#3101COMPOITIONS AND METHODS FOR MODULATING THERMOGENESIS USING PTH-RELATED AND EGF-RELATED COMPOUNDS
#3102Diagnosis and Risk Assessment of Pancreatic Diabetes Using MR-proADM
#3103Marker for statin treatment stratification in heart failure
#3104Non-Glycosylated suPar Biomarkers and Uses Thereof
#3105COMPOSITION CONTAINING PYRUVATE DEHYDROGENASE KINASE INHIBITOR FOR TREATING CHRONIC INFLAMMATORY PAIN
#3106METHOD FOR PROGNOSIS OF THE EFFICACY OF ORAL IMMUNOTHERAPY FOR THE TREATMENT OF ALLERGY TO PROTEINS IN COW'S MILK
#3107Compositions, methods and kits for diagnosis of lung cancer
#3108Test apparatus and methods for ST2 cardiac biomarker
#3109Diagnosis of sepsis
#3110Human anti-SOD1 antibodies
#3111TRANSTHYRETIN AMYLOID-SELECTIVE AND POLYREACTIVE CATABODIES
#3112Diagnosis of respiratory tract infectious disease using blood specimens
#3113DIAGNOSIS AND RISK STRATIFICATION USING NT-proET-1
#3114METHOD FOR PREDICTING TREATMENT RESPONSE AND TEST FOR SAFE USE OF MESENCHYMAL STEM CELLS ON INFLAMMATORY DISEASES
#3115Diagnostic method for inflammatory bowel disease
#3116AFFINITY CAPTURE OF CIRCULATING BIOMARKERS
#3117Inflammatory bowel disease markers and therapies for colitis-associated intestinal fibrosis
#3118Methods and compositions for treating and diagnosing diseases
#3119Urine-based immuncassay for urocirtub 3 abd duagbisus if skeeo aobea
#3120Methods of Detecting Kidney-Associated Diseases or Conditions
#3121Anti-human CD26 monoclonal antibody or antigen-binding fragment thereof
#3122Methods of modulating the activity of adrenomedullin in a subject in need of regulation of fluid balance by administering an anti-adrenomedullin (ADM) antibody or an anti-ADM antibody fragment
#3123Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
#3124Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
#3125Means and methods for diagnosing heart failure in a subject
#3126Atypical hemolytic uremic syndrome (AHUS) biomarker proteins
#3127Test fluid collection system
#3128Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition
#3129Milk fat globule epidermal growth factor 8 regulates fatty acid uptake
#3130USE OF ALPHA-CRYSTALLIN B (CRYAB) IN THE ASSESSMENT OF HEART FAILURE
#3131Therapeutic agent, method of treatment and method for predicting the severity of systemic inflammatory response syndrome (SIRS), diseases caused or accompanied by neutrophil activation
#3132DIAGNOSTIC ASSAY TO PREDICT CARDIOVASCULAR RISK
#3133STRESS AND INFLAMMATION BIOMARKER URINE PANEL FOR DAIRY COWS AND BEEF CATTLE
#3134METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#3135Bladder cancer detection composition, kit, and associated methods
#3136Modified Variable Domain Molecules And Methods For Producing And Using Same
#3137JOHNSON GRASS ALLERGENIC POLLEN PROTEINS, ENCODING NUCLEIC ACIDS AND METHODS OF USE
#3138CHI3L1 FOR THE DETECTION AND TREATMENT OF NONALCOHOLIC STEATOHEPATITIS
#3139Pathway specific markers for diagnosing irritable bowel syndrome
#3140Method for aiding differential diagnosis of stroke
#3141BIOMARKERS FOR TREATMENT WITH ANTI-TUBULIN CHEMOTHERAPEUTIC COMPOUNDS
#3142Methods for assessing vaginal atrophy
#3143Methods for the prediction, prognosis, and/or diagnosis of an inflammatory response associated with schizophrenia
#3144Biomarker for psychiatric and neurological disorders
#3145PHOSPHORYLCHOLINE CONJUGATES AND CORRESPONDING ANTIBODIES
#3146In vitro method for early or differential diagnosis or prognosis of myocardial infarction in a patient
#3147T CELL EPITOPES DERIVED FROM ALT A 1 OR ALT A 5 FOR THE TREATMENT OF ALTERNARIA ALTERNATA ALLERGY
#3148Pathway specific assays for predicting irritable bowel syndrome diagnosis
#3149METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#3150Biomarker of rehospitalization after heart failure
#3151Aiding assessment of prognosis in inflammatory disease by measuring octameric PTX
#3152Collagen Type X Alpha-1 Assay
#3153Multiple hybrid immunoassay
#3154Methods for detection of depressive disorders
#3155Blood markers for diagnosing epithelium derived cancers and monoclonal antibodies thereof
#3156Biological markers useful in cancer immunotherapy
#3157COMPOSITIONS AND METHODS COMPRISING BACTERIA FOR IMPROVING BEHAVIOR IN NEURODEVELOPMENTAL DISORDERS
#3158IN VITRO DETECTION OF PRIONS IN BLOOD
#3159Biomarkers related to kidney function and methods using the same
#3160Systems and methods for characterizing kidney diseases
#3161Detection of an immune response
#3162BIOMARKER OF Nrf2 ACTIVATION
#3163PRODRUGS AND DRUGS
#3164Treatment of insulin resistance through inhibitors of transcription factor TSC22D4
#3165GDF-15 and/or Troponin T for Predicting Kidney Failure in Heart Surgery Patients
#3166Methods for Safe Administration of Nephrotoxic Agents
#3167Tuberculosis Biomarkers and Uses Thereof
#3168FEN1 AS A MARKER FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
#3169Methods And Compositions For Determining Fortilin Levels
#3170Compositions And Methods For Heparan Sulfate As A Biomarker For Transplant Rejection
#3171Methods for diagnosing and treating bicuspid aortic valve and/or aortopathies
#3172Biomarker panel for dose assessment of radiation injury and micro plasma filter
#3173Anti-CXCL1, CXCL7 and CXCL8 antibodies and their applications
#3174METHODS OF DIAGNOSING AND TREATING ASTHMA
#3175Methods for diagnosis and treatment of concussion or brain injury
#3176Diagnostic kit for diagnosis of abnormal protein aggregation- or misfolding-related diseases using dissociation of protein aggregates
#3177METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#3178Method for diagnosis and prognosis of chronic obstructive pulmonary disease (COPD)
#3179DISTINCT EFFECTS OF IFN-GAMMA AND IL-17 ON TL1A MODULATED INFLAMMATION AND FIBROSIS
#3180Galactoside inhibitor of galectins
#3181Fibrosis biomarker assay
#3182METHOD FOR DIAGNOSING AND TREATING CROHN'S DISEASE
#3183Highly Sensitive Biomarker Panels
#3184Calibration for multi-component assays
#3185Biomarker composite test for hepatic vein pressure gradient and cirrhosis treatment
#3186Methods and compositions for determining and treating relapse in inflammatory bowel disease
#3187In vitro method for the early detection of a potential inflammation, in particular associated with rejection of a transplant, a neurodegenerative disorder or a depression
#3188Methods for treating ADHD and bipolar disorder using a membrane potential ratio test
#3189Therapeutic and imaging compositions and uses thereof
#3190CLINICAL DIAGNOSIS OF HEPATIC FIBROSIS USING A NOVEL PANEL OF HUMAN SERUM PROTEIN BIOMARKERS
#3191PERSONALISED MEDICINE
#3192Target for diagnosis and treatment of diabetes and cardiovascular diseases
#3193HEALTH TEST FOR A BROAD SPECTRUM OF HEALTH PROBLEMS
#3194Compositions and Methods for Detection of Defensins in a Patient Sample
#3195Methods for Early Diagnosis of Kidney Disease
#3196Methods of identifying compounds for the treatment of fibrosis by using S1PR5
#3197Method for evaluating atherosclerotic lesion, and kit
#3198Compositions and methods for treating steroid resistant nephrotic syndrome and/or steroid sensitive nephrotic syndrome
#3199Antibody to cytolethal distending toxin of Campylobacter jejuni
#3200Methods for predicting risk of interstitial pneumonia
#3201Mathematical musical orchestral method for predicting classes of patients for medical treatment
#3202Methods for Predicting Cardiovascular Mortality Risk
#3203Method for determining radiosensitivity
#3204Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#3205Genospecific radiosensitization
#3206Thyroglobulin quantitation by mass spectroscopy
#3207Methods of inhibiting complement C4 activation with anti-complement C1s antibodies
#3208Recombinant human antibodies for therapy and prevention of polyomavirus-related diseases
#3209Antibody molecules
#3210Methods for determining the risk of cardiovascular disease in a subject having a chronic viral infection
#3211COMPOSITIONS AND METHODS RELATED TO OBSTRUCTIVE SLEEP APNEA
#3212Thyroglobulin quantitation by mass spectrometry
#321314-3-3 eta antibodies and uses thereof for the diagnosis and treatment of arthritis
#3214PREDICTING AND REDUCING ALLOIMMUNOGENICITY OF PROTEIN THERAPEUTICS
#3215Measurement of FGF21 as a biomarker of fructose metabolism
#32162-HYDROXYGLUTARATE AS A BIOMARKER FOR CHRONIC HYPOXIA
#3217Use of ACY-1 as a marker of ischaemia/reperfusion, delayed graft function and graft viability as well as method thereof
#3218Alpha-keto-isovalerate as a biomarker of prebiotic efficacy for weight gain prevention
#3219Indoxyl sulfate as a biomarker of prebiotic efficacy for weight gain prevention
#3220Trimethylamine as a biomarker of prebiotic efficacy for weight gain prevention
#3221METHODS OF DIAGNOSING ENDOMETRIOSIS
#3222METHODS AND COMPOSITIONS USEFUL IN MANIPULATING THE STABILITY OF RE1 SILENCING TRANSCRIPTION FACTOR
#3223Amyloidosis-inhibiting polypeptides and their use
#3224Glycosidase inhibitors
#3225Methods for the treatment of autoimmune diseases
#3226Methods and Compositions for Preventing Metastasis and for Improving the Survival Time
#3227Pre-eclampsia biomarkers
#3228Compositions and methods for predicting age of onset of a lysosomal storage disease or a disease associated with a lysosomal defect
#3229Promoting Apoptosis Of Differentiated Adipocytes And Increasing Endogenous Expression Of sFRP-5 Peptide By Adipocytes By Administration Of sFRP-5 Peptide
#3230DIAGNOSIS AND TREATMENT OF FIBROSIS
#3231Methods for increasing the selective efficacy of gene therapy using CAR peptide and heparan-sulfate mediated macropinocytosis
#3232Treatment of insulin resistance associated with prolonged physical inactivity
#3233Marker for diagnosing diabetic retinopathy and use thereof
#3234SAB as a Biomarker for Degenerative Diseases and Therapeutic Sensitivity in Cancers
#3235Methods of Prognosing Preeclampsia
#3236METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#3237USE OF SEPRASE FOR DIFFERENTIAL DIAGNOSIS OF ACUTE DYSPNEA
#3238Method and kit for making an in vitro prognosis of severity for a patient in septic shock
#3239HSP90-targeted cardiac imaging and therapy
#3240Lipopeptides for use in treating liver diseases and cardiovascular diseases
#3241Methods of Treating Acute Kidney Injury
#3242Animal model of Charcot-Marie-Tooth disease as HSP27 mutant (S135F) carrier
#3243QUANTITATIVE DIAGNOSTIC METHODS USING MULTIPLE PARAMETERS
#3244METHODS TO PREDICT AND PREVENT RESISTANCE TO TAXOID COMPOUNDS
#3245TROPONIN AND BNP BASED DIAGNOSIS OF RISK PATIENTS AND CAUSE OF STROKE
#3246Application of N-terminomics to NETosis in inflammation
#3247ASSAY FOR POLYPEPTIDE AGGREGATION USING MICRODROPLETS
#3248DIAGNOSIS AND THERAPY OF CHRONIC INFLAMMATION-INDUCED DISORDERS
#3249SALIVARY BIOASSAY FOR EARLY DETECTION OF BONE LOSS
#3250Hexanoylglycine as biomarker for the predisposition for weight gain and obesity
#3251Clinical decision support (CDS) for radiotherapy in prostate cancer
#3252Tau imaging probe
#3253Treatment of Acute Tubular Necrosis or Acute Tubule-Interstitial Nephropathy
#3254METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#3255Diagnostic method for diagnosing depression and monitoring therapy effectiveness
#3256Multiplex colon cancer marker panel
#3257Biodosimetry panels and methods
#3258Inhibition of SEMA3A in the prevention and treatment of ocular hyperpermeability
#3259Nucleic acids encoding FHL1 mutations associated with novel X-linked muscular myopathies and methods of screening a subject
#3260Probiotic Strains for Treating and/or Preventing Diarrhea
#3261Method for determining and treating amyotrophic lateral sclerosis
#3262Biomarkers for fatty liver disease and methods using the same
#3263Biomarkers and methods for measuring and monitoring inflammatory disease activity
#3264Methods of diagnosing, treating and monitoring diabetic retinopathy
#3265Diagnosis Of Rheumatoid Arthritis
#3266BIOMARKERS FOR RADIATION EXPOSURE
#3267METHODS FOR DIAGNOSIS OF KAWASAKI DISEASE
#3268Chronic obstructive pulmonary disease (COPD) biomarkers and uses thereof
#3269Serological methods and diagnostic tests for syphilis antibodies
#3270Method for determining acute respiratory distress syndrome (ARDS) related biomarkers, a method to monitor the development and treatment of ARDS in a patient
#3271BIOMARKER ASSAY FOR DIAGNOSIS AND CLASSIFICATION OF CARDIOVASCULAR DISEASE
#3272Methods of producing antibodies specific for p95
#3273Methods for treating and diagnosing systemic lupus erythematosus
#3274METHOD TO IDENTIFY PATIENTS THAT WILL LIKELY RESPOND TO ANTI-TNF THERAPY
#3275HER3 protein SRM/MRM assay
#3276Platelet biomarkers in cancer diagnosis
#3277Methods and devices for determining a disease state
#3278Dendritic cell response gene expression, compositions of matters and methods of use thereof
#3279Human monoclonal antibodies specific for glypican-3 and use thereof
#3280Compostions and methods for treating chemosensory dysfunction
#3281Biomarkers related to insulin resistance progression and methods using the same
#3282Method for Differentiating Sepsis and Systemic Inflammatory Response Syndrome (SIRS)
#3283Assays for determining levels of plasma protease C1 inhibitor
#3284Identification of unique gene expression profiles in children with regressive autism spectrum disorder (ASD) and ileocolitis
#3285Dipeptide-repeat proteins as therapeutic target in neurodegenerative diseases with hexanucleotide repeat expansion
#3286Method of assessing a subject for abnormal kidney function
#3287Biomarkers for differentiating between non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD)
#3288Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#3289METHODS FOR PREDICTING AND MONITORING MUCOSAL HEALING
#3290MARKERS FOR LIPID METABOLISM
#3291Differential expression of protein markers for the diagnosis and treatment of eosinophilic esophagitis
#3292Markers associated with arteriovascular events and methods of use thereof
#3293USE OF sCD14 OR ITS FRAGMENTS OR DERIVATIVES FOR RISK STRATIFICATION, DIAGNOSIS AND PROGNOSIS
#3294AUTOSOMAL-DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)
#3295Methods for the diagnosis of fetal abnormalities
#3296Compositions and methods for diagnosing and treating an inflammation
#3297Method to predict response to pharmacological chaperone treatment of diseases
#3298METHOD FOR OBTAINING DATA THAT ARE USEFUL FOR THE DIAGNOSIS, PROGNOSIS AND CLASSIFICATION OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND/OR LUNG CANCER
#3299Non-invasive diagnostic method for the evaluation of intestinal lactase deficiency (hypolactasia)
#3300Method for in vitro detection and monitoring of a disease by measuring disease-associated protease activity in extracellular vesicles